Immunohistochemical labelling for prostate–specific antigen in breast carcinomas

被引：0
|
作者：
Kalle A. Alanen
Teijo Kuopio
Yrjö U. Collan
Pauliina Kronqvist
Laura Juntti
Timo J. Nevalainen
机构：
[1] University of Turku and University Central Hospital of Turku,Department of Pathology
来源：
Breast Cancer Research and Treatment | 1999年 / 56卷 / 2期
关键词：
breast carcinoma; menopausal status; prognosis; prostate–specific antigen; steroid hormone receptors;
D O I：
10.1023/A:1006210627219
中图分类号：
学科分类号：
摘要：
Immunohistochemical detection of prostate–specific antigen (PSA) is an aid in determining the prostatic origin of metastatic cells. However, small amounts of PSA have also been found in non–prostatic tissues and tumors, for example in some breast carcinomas, by highly sensitive immunofluorometric methods, but also by immunohistochemistry. Our aim was to evaluate the prevalence and prognostic value of histologically confirmed PSA immunoreactivity in breast carcinoma.
引用
收藏
页码：167 / 174
页数：7
相关论文
共 50 条
  • [21] Evaluation of Prostate Specific Membrane Antigen (PSMA) immunohistochemical expression in early-stage breast cancer subtypes
    Andryszak, N.
    Kurzawa, P.
    Krzyzaniak, M.
    Nowicki, M.
    Ruchala, M.
    Izycki, D.
    Czepczynski, R.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 90 - 90
  • [22] Immunohistochemical characterization of 53 monoclonal antibodies to prostate-specific antigen
    Nap, M
    van der Kwast, TM
    TUMOR BIOLOGY, 1999, 20 : 38 - 42
  • [23] Immunoreactivity of prostate-specific antigen in male breast carcinomas - Two examples of a diagnostic pitfall in discriminating a primary breast cancer from metastatic prostate carcinoma
    Gupta, RK
    DIAGNOSTIC CYTOPATHOLOGY, 1999, 21 (03) : 167 - 169
  • [24] The significance of prostate specific antigen (PSA) in breast cancer
    Klijn, JGM
    Diamandis, EP
    Yu, H
    Look, MP
    Gelder, MEMV
    van Putten, WLJ
    Foekens, JA
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S106 - S107
  • [25] Prostate-specific membrane antigen in breast carcinoma
    Uria, JA
    Velasco, G
    Santamaria, I
    Ferrando, A
    LopezOtin, C
    LANCET, 1997, 349 (9065): : 1601 - 1601
  • [26] Expression of prostate specific antigen in male breast cancer
    Carder, PJ
    Speirs, V
    Ramsdale, J
    Lansdown, MRJ
    JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (01) : 69 - 71
  • [27] Prostate specific antigen (PSA) in breast and ovarian cancer
    Kucera, E
    Kainz, C
    Tempfer, C
    Zeillinger, R
    Koelbl, H
    Sliutz, G
    ANTICANCER RESEARCH, 1997, 17 (6D) : 4735 - 4737
  • [28] Troubleshooting immunohistochemical labelling of proliferating cell nuclear antigen (PCNA) in cryocut tissue sections of mouse prostate
    Xie, Jin Han
    Hollande, Frederic
    Haynes, John M.
    Pouton, Colin W.
    Ventura, Sabatino
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2010, 61 (02) : 98 - 101
  • [29] Prostate-specific antigen in breast cyst fluid: Possible role of prostate-specific antigen in hormone-dependent breast cancer
    Lai, LC
    Erbas, H
    Lennard, TWJ
    Peaston, RT
    INTERNATIONAL JOURNAL OF CANCER, 1996, 66 (06) : 743 - 746
  • [30] Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas
    Stege, R
    Grande, M
    Carlström, K
    Tribukait, B
    Pousette, Å
    CLINICAL CANCER RESEARCH, 2000, 6 (01) : 160 - 165
12345